{"entity":{"type":"insider","cik":"0001533277","url":"/insider/0001533277","json_url":"/insider/0001533277.json","name":"FRD Acquisition Corp","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":2,"first":"2011-12-09","last":"2011-12-13","span_basis":"filed_date"},"name_variants":[{"name":"FRD Acquisition Corp","source":"filing","n_filings":2,"first_seen":"2011-12-09","last_seen":"2011-12-13"}],"transactions":[{"id":9118157,"accession":"0001104659-11-069251","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-11-069251","line_url":"/filing/0001104659-11-069251#line-3","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"ADOLOR CORP","issuer_ticker":"ADLR","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":null,"owner_name":"FRD Acquisition Corp; CUBIST PHARMACEUTICALS INC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7908727.0,"shares_display":"7,908,727","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":33612089.75,"total_display":"33,612,089.75","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-12","filed_date":"2011-12-13","scope":"insider"},{"id":9118156,"accession":"0001104659-11-069251","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-11-069251","line_url":"/filing/0001104659-11-069251#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"ADOLOR CORP","issuer_ticker":"ADLR","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":null,"owner_name":"FRD Acquisition Corp; CUBIST PHARMACEUTICALS INC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45070030.0,"shares_display":"45,070,030","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":214533342.8,"total_display":"214,533,342.80","shares_owned_after":88377182.0,"shares_owned_after_display":"88,377,182","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-09","filed_date":"2011-12-13","scope":"insider"},{"id":9118155,"accession":"0001104659-11-069251","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-11-069251","line_url":"/filing/0001104659-11-069251#line-1","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"ADOLOR CORP","issuer_ticker":"ADLR","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":null,"owner_name":"FRD Acquisition Corp; CUBIST PHARMACEUTICALS INC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1729130.0,"shares_display":"1,729,130","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":7348802.5,"total_display":"7,348,802.50","shares_owned_after":43307152.0,"shares_owned_after_display":"43,307,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-09","filed_date":"2011-12-13","scope":"insider"},{"id":9003603,"accession":"0001104659-11-068718","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-11-068718","line_url":"/filing/0001104659-11-068718#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"ADOLOR CORP","issuer_ticker":"ADLR","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":null,"owner_name":"FRD Acquisition Corp; CUBIST PHARMACEUTICALS INC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1180983.0,"shares_display":"1,180,983","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":5019177.75,"total_display":"5,019,177.75","shares_owned_after":41578022.0,"shares_owned_after_display":"41,578,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-08","filed_date":"2011-12-09","scope":"insider"},{"id":9003602,"accession":"0001104659-11-068718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-11-068718","line_url":"/filing/0001104659-11-068718#line-1","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"ADOLOR CORP","issuer_ticker":"ADLR","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":null,"owner_name":"FRD Acquisition Corp; CUBIST PHARMACEUTICALS INC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4306129.0,"shares_display":"4,306,129","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":18301048.25,"total_display":"18,301,048.25","shares_owned_after":40397039.0,"shares_owned_after_display":"40,397,039","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-07","filed_date":"2011-12-09","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001076167","name":"ADOLOR CORP","url":"/issuer/0001076167","role":"Ten percent owner","n_filings":2,"first_seen":"2011-12-09","last_seen":"2011-12-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001533277","retrieved_at":"2026-08-21T09:48:50+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}